{"success":true,"data":{"pressRelease":{"id":"162759","rtpr_id":"nNFC6sxhs3-20261007","ticker":"HEAL","exchange":"","all_tickers":["HEAL"],"title":"Restart Life Advances Licensed Intellectual Property Portfolio Toward Commercial Launch","author":"Newsfile Corp","published_at":"2026-10-07T10:00:16.142Z","article_body":"Vancouver, British Columbia--(Newsfile Corp. - October 7, 2026) - Restart Life\nSciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) (\"Restart Life\" or\nthe \"Company\") is pleased to provide an update regarding the strategic\ntrademark licensing agreement originally announced on March 14, 2025 and\nupdated on May 15, 2026.\n\nSince the May update, the Company has continued to advance the\ncommercialization of the licensed intellectual property (\"IP\"). Multiple brand\nand product concepts have progressed through formulation, branding, packaging\nand production planning, with products now being prepared for future launch\nunder the Restart Life portfolio.\n\nRecent product development efforts have focused on initiatives closest to\ncommercialization, including the launch of Holy Crap Protein+, continued\ndevelopment of the previously announced HC Kids line and other products that\nhave launched or are approaching commercial readiness.\n\nWith those initiatives advancing, management is increasing its focus on the\npositioning and commercialization of the additional licensed IP.\n\nThe licensing agreement provides Restart Life with exclusive rights to certain\nhealth-related trademarks for an initial five-year term, together with a\nfive-year renewal option.\n\nThe Company has undertaken formulation, branding, manufacturing, regulatory,\ndistribution and e-commerce planning related to the licensed properties and is\nnow advancing selected products toward commercial launch.\n\nManagement currently sees two principal commercialization paths.\n\nCertain products may be launched as standalone Restart Life brands and\nintroduced through existing direct-to-consumer, marketplace and distribution\nchannels.\n\nOther products may be incorporated into existing brands as complementary or\nadd-on offerings intended to broaden the product assortment available to\nexisting customers.\n\nThis approach allows Restart Life to preserve independent brand identities\nwhere appropriate while utilizing shared manufacturing, marketing, e-commerce\nand distribution infrastructure.\n\nNo final determination has been made regarding the commercial structure or\nlaunch sequence of all licensed properties.\n\nExisting Operating Platform\n\nHoly Crap remains the Company's flagship operating consumer brand.\n\nDuring 2026, Restart Life expanded the Holy Crap portfolio through the launch\nof Protein+ and continued development of additional lines, including HC Kids.\n\nThrough Holy Crap and its broader development activities, Restart Life has\nestablished or is developing capabilities across manufacturing, product\ndevelopment, sourcing, packaging, e-commerce, marketplaces, marketing and\ndistribution.\n\nManagement intends to use this infrastructure, where commercially appropriate,\nto support products developed under the licensed IP portfolio.\n\n\"Our initial priority has been to execute on products closest to\ncommercialization, including Holy Crap Protein+ and the HC Kids line,\" said\nSteve Loutskou, Chief Executive Officer of Restart Life Sciences Corp.\n\n\"As those initiatives have advanced, we have continued developing the\nadditional intellectual property licensed by Restart Life. Depending on the\nproduct, these properties may be launched as independent brands through\nexisting sales channels or integrated into existing brands as complementary\nproducts.\"\n\nThe timing and structure of individual launches will depend on production\nreadiness, regulatory requirements, available working capital and management's\nassessment of market conditions.\n\nThere can be no assurance regarding the timing of any commercial launch or the\nlevel of future revenue, if any, generated from products developed under the\nlicensing agreement.\n\nThe Company will provide further updates as individual brands and products\nreach material commercialization milestones.\n\nRestart Life Sciences would like to thank its shareholders for their ongoing\nsupport as the Company advances its mission and continues to execute on its\nstrategy.\n\nAbout Restart Life Sciences Corp.\nRestart Life Sciences Corp. is a Canadian-based life sciences company listed\non the CSE. For more information about Restart Life, please visit the\nCompany's website at www.restartlife.co.\n\nAbout Holy Crap Foods Inc.\nHoly Crap Superseed Cereal and Holy Crap Superseed Oatmeal are premium\nfunctional food brands offering nutrient-dense, clean-label products made with\nsimple, high-quality ingredients. Based in Gibsons, British Columbia, the\nbrand has built a loyal and growing customer base across Canada, driven by\nstrong consumer trust and repeat purchases.\n\nPositioned within the fast-growing gut health and wellness category, Holy\nCrap's gluten-free, non-GMO, high-fiber products support digestive health and\nsustained energy, while gaining traction as a trusted, everyday solution for\nhealth-conscious consumers. For more information, visit www.holycrap.com\n\nForward-Looking Statements\nThis news release contains statements that constitute \"forward-looking\nstatements.\" Such forward-looking statements involve known and unknown risks,\nuncertainties and other factors that may cause Restart Life Sciences' actual\nresults, performance or achievements, or developments in the industry to\ndiffer materially from the anticipated results, performance or achievements\nexpressed or implied by such forward-looking statements. Forward-looking\nstatements are statements that are not historical facts and are generally, but\nnot always, identified by the words \"expects,\" \"plans,\" \"anticipates,\"\n\"believes,\" \"intends,\" \"estimates,\" \"projects,\" \"potential\" and similar\nexpressions, or that events or conditions \"will,\" \"would,\" \"may,\" \"could\" or\n\"should\" occur.\n\nNeither the Canadian Securities Exchange nor its Market Regulator (as that\nterm is defined in the policies of the Canadian Securities Exchange) accepts\nresponsibility for the adequacy or accuracy of this release.\n\nOn behalf of the Board of Directors\nSteve Loutskou\nChief Executive Officer, Restart Life Sciences Corp.\nTel: +1 (778) 819-0244\nEmail: hello@restartlife.co\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/317803","article_body_html":"","raw_payload":{"data":{"id":"nNFC6sxhs3-20261007","title":"Restart Life Advances Licensed Intellectual Property Portfolio Toward Commercial Launch","author":"Newsfile Corp","ticker":"HEAL","created":"2026-10-07T10:00:16.142Z","tickers":["HEAL"],"exchange":"","article_body":"Vancouver, British Columbia--(Newsfile Corp. - October 7, 2026) - Restart Life\nSciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) (\"Restart Life\" or\nthe \"Company\") is pleased to provide an update regarding the strategic\ntrademark licensing agreement originally announced on March 14, 2025 and\nupdated on May 15, 2026.\n\nSince the May update, the Company has continued to advance the\ncommercialization of the licensed intellectual property (\"IP\"). Multiple brand\nand product concepts have progressed through formulation, branding, packaging\nand production planning, with products now being prepared for future launch\nunder the Restart Life portfolio.\n\nRecent product development efforts have focused on initiatives closest to\ncommercialization, including the launch of Holy Crap Protein+, continued\ndevelopment of the previously announced HC Kids line and other products that\nhave launched or are approaching commercial readiness.\n\nWith those initiatives advancing, management is increasing its focus on the\npositioning and commercialization of the additional licensed IP.\n\nThe licensing agreement provides Restart Life with exclusive rights to certain\nhealth-related trademarks for an initial five-year term, together with a\nfive-year renewal option.\n\nThe Company has undertaken formulation, branding, manufacturing, regulatory,\ndistribution and e-commerce planning related to the licensed properties and is\nnow advancing selected products toward commercial launch.\n\nManagement currently sees two principal commercialization paths.\n\nCertain products may be launched as standalone Restart Life brands and\nintroduced through existing direct-to-consumer, marketplace and distribution\nchannels.\n\nOther products may be incorporated into existing brands as complementary or\nadd-on offerings intended to broaden the product assortment available to\nexisting customers.\n\nThis approach allows Restart Life to preserve independent brand identities\nwhere appropriate while utilizing shared manufacturing, marketing, e-commerce\nand distribution infrastructure.\n\nNo final determination has been made regarding the commercial structure or\nlaunch sequence of all licensed properties.\n\nExisting Operating Platform\n\nHoly Crap remains the Company's flagship operating consumer brand.\n\nDuring 2026, Restart Life expanded the Holy Crap portfolio through the launch\nof Protein+ and continued development of additional lines, including HC Kids.\n\nThrough Holy Crap and its broader development activities, Restart Life has\nestablished or is developing capabilities across manufacturing, product\ndevelopment, sourcing, packaging, e-commerce, marketplaces, marketing and\ndistribution.\n\nManagement intends to use this infrastructure, where commercially appropriate,\nto support products developed under the licensed IP portfolio.\n\n\"Our initial priority has been to execute on products closest to\ncommercialization, including Holy Crap Protein+ and the HC Kids line,\" said\nSteve Loutskou, Chief Executive Officer of Restart Life Sciences Corp.\n\n\"As those initiatives have advanced, we have continued developing the\nadditional intellectual property licensed by Restart Life. Depending on the\nproduct, these properties may be launched as independent brands through\nexisting sales channels or integrated into existing brands as complementary\nproducts.\"\n\nThe timing and structure of individual launches will depend on production\nreadiness, regulatory requirements, available working capital and management's\nassessment of market conditions.\n\nThere can be no assurance regarding the timing of any commercial launch or the\nlevel of future revenue, if any, generated from products developed under the\nlicensing agreement.\n\nThe Company will provide further updates as individual brands and products\nreach material commercialization milestones.\n\nRestart Life Sciences would like to thank its shareholders for their ongoing\nsupport as the Company advances its mission and continues to execute on its\nstrategy.\n\nAbout Restart Life Sciences Corp.\nRestart Life Sciences Corp. is a Canadian-based life sciences company listed\non the CSE. For more information about Restart Life, please visit the\nCompany's website at www.restartlife.co.\n\nAbout Holy Crap Foods Inc.\nHoly Crap Superseed Cereal and Holy Crap Superseed Oatmeal are premium\nfunctional food brands offering nutrient-dense, clean-label products made with\nsimple, high-quality ingredients. Based in Gibsons, British Columbia, the\nbrand has built a loyal and growing customer base across Canada, driven by\nstrong consumer trust and repeat purchases.\n\nPositioned within the fast-growing gut health and wellness category, Holy\nCrap's gluten-free, non-GMO, high-fiber products support digestive health and\nsustained energy, while gaining traction as a trusted, everyday solution for\nhealth-conscious consumers. For more information, visit www.holycrap.com\n\nForward-Looking Statements\nThis news release contains statements that constitute \"forward-looking\nstatements.\" Such forward-looking statements involve known and unknown risks,\nuncertainties and other factors that may cause Restart Life Sciences' actual\nresults, performance or achievements, or developments in the industry to\ndiffer materially from the anticipated results, performance or achievements\nexpressed or implied by such forward-looking statements. Forward-looking\nstatements are statements that are not historical facts and are generally, but\nnot always, identified by the words \"expects,\" \"plans,\" \"anticipates,\"\n\"believes,\" \"intends,\" \"estimates,\" \"projects,\" \"potential\" and similar\nexpressions, or that events or conditions \"will,\" \"would,\" \"may,\" \"could\" or\n\"should\" occur.\n\nNeither the Canadian Securities Exchange nor its Market Regulator (as that\nterm is defined in the policies of the Canadian Securities Exchange) accepts\nresponsibility for the adequacy or accuracy of this release.\n\nOn behalf of the Board of Directors\nSteve Loutskou\nChief Executive Officer, Restart Life Sciences Corp.\nTel: +1 (778) 819-0244\nEmail: hello@restartlife.co\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/317803"},"type":"article","timestamp":"2026-10-07T10:00:16.191139617Z","server_sent_at_ms":1791367216191},"received_at":"2026-10-07T10:00:16.241Z","source_url":"https://www.newsfilecorp.com/release/317803"},"analysis":{"id":"151236","press_release_id":"162759","analysis_json":{"industry":{"label":"Packaged Foods & Meats","sector":"Consumer Staples"},"redFlags":["No commercial structure or launch sequence finalized for licensed properties","No revenue or financial figures disclosed; explicit no-assurance language on launch timing and future revenue","Working capital availability cited as a launch dependency"],"eventType":"operations_update","narrative":"Restart Life Sciences provided an update on commercializing the health-related trademark IP licensed exclusively since March 2025 for a five-year term with a five-year renewal option.\n\nProducts closest to launch include Holy Crap Protein+ and the HC Kids line; licensed properties may be sold as standalone brands or folded into existing brands using shared manufacturing, e-commerce and distribution infrastructure.\n\nThe release contains no financial figures or firm launch dates, and management explicitly cautions there is no assurance of launch timing or future revenue.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Micro-cap promotional-style update on licensed IP commercialization with no hard numbers -- monitor for actual launch milestones."},"keyFigures":{"customDimensions":{"license_initial_term_years":5,"license_renewal_option_years":5}},"quotedText":"There can be no assurance regarding the timing of any commercial launch or the level of future revenue, if any, generated from products developed under the licensing agreement.","namedEntities":{"people":[{"name":"Steve Loutskou","role":"Chief Executive Officer"}],"products":["Holy Crap Protein+","HC Kids","Holy Crap Superseed Cereal","Holy Crap Superseed Oatmeal"],"companies":[{"name":"Restart Life Sciences Corp.","ticker":"HEAL"},{"name":"Holy Crap Foods Inc.","relationship":"flagship consumer brand/subsidiary brand"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Routine commercialization progress update on licensed IP with no financial figures, revenue, or definitive launch dates. Management itself cautions there is no assurance of launch timing or any future revenue."},"tickerRelevance":{"others":[{"ticker":"HN30","relevance":"Frankfurt listing of the same issuer"},{"ticker":"NMLSF","relevance":"OTC Pink listing of the same issuer"}],"primary":"HEAL"},"globalImportance":8,"audienceRelevance":5,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap CSE listing","eventGravity":"routine commercialization update","financialDisclosure":"none","retailFavoriteBoost":false}},"event_type":"operations_update","event_type_secondary":null,"sentiment":"neutral","material_impact_score":2,"narrative":"Restart Life Sciences provided an update on commercializing the health-related trademark IP licensed exclusively since March 2025 for a five-year term with a five-year renewal option.\n\nProducts closest to launch include Holy Crap Protein+ and the HC Kids line; licensed properties may be sold as standalone brands or folded into existing brands using shared manufacturing, e-commerce and distribution infrastructure.\n\nThe release contains no financial figures or firm launch dates, and management explicitly cautions there is no assurance of launch timing or future revenue.","key_figures":{"customDimensions":{"license_initial_term_years":5,"license_renewal_option_years":5}},"named_entities":{"people":[{"name":"Steve Loutskou","role":"Chief Executive Officer"}],"products":["Holy Crap Protein+","HC Kids","Holy Crap Superseed Cereal","Holy Crap Superseed Oatmeal"],"companies":[{"name":"Restart Life Sciences Corp.","ticker":"HEAL"},{"name":"Holy Crap Foods Inc.","relationship":"flagship consumer brand/subsidiary brand"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-07T10:00:21.917Z","global_importance":8,"audience_relevance":5,"importance_components":{"tickerTier":"micro-cap CSE listing","eventGravity":"routine commercialization update","financialDisclosure":"none","retailFavoriteBoost":false}},"durationMs":5659,"modelName":"glm-5.3-flashx"}}